DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 56 filers reported holding DEXCOM INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $25,393,863 | -11.7% | 25,365,000 | -3.1% | 0.00% | 0.0% |
| Q1 2024 | $28,774,437 | +5.3% | 26,165,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $27,322,358 | -8.5% | 26,165,000 | -17.4% | 0.00% | -50.0% |
| Q3 2023 | $29,868,114 | -5.0% | 31,665,000 | +7.5% | 0.00% | 0.0% |
| Q2 2023 | $31,443,222 | +22.8% | 29,465,000 | +23.2% | 0.00% | +100.0% |
| Q1 2023 | $25,609,786 | -58.5% | 23,915,000 | -57.9% | 0.00% | -50.0% |
| Q4 2022 | $61,779,962 | +149.0% | 56,830,000 | +112.3% | 0.00% | 0.0% |
| Q3 2022 | $24,812,000 | +6.6% | 26,765,000 | +5.5% | 0.00% | +100.0% |
| Q2 2022 | $23,281,000 | -29.3% | 25,365,000 | -11.7% | 0.00% | -50.0% |
| Q1 2022 | $32,921,000 | -15.8% | 28,725,000 | -13.0% | 0.00% | 0.0% |
| Q4 2021 | $39,099,000 | -11.4% | 33,025,000 | -10.8% | 0.00% | 0.0% |
| Q3 2021 | $44,108,000 | +25.4% | 37,025,000 | +10.3% | 0.00% | 0.0% |
| Q2 2021 | $35,179,000 | – | 33,560,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PIER 88 INVESTMENT PARTNERS LLC | 17,495,000 | $16,120,000 | 3.83% |
| SSI INVESTMENT MANAGEMENT LLC | 34,177,000 | $31,482,000 | 2.11% |
| Liberty Mutual Group Asset Management Inc. | 4,075,000 | $3,754,000 | 1.13% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 64,568,000 | $59,806,000 | 1.08% |
| MACKAY SHIELDS LLC | 43,555,000 | $40,304,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 18,523,000 | $17,071,000 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,022,000 | $8,360,000 | 0.76% |
| Calamos Advisors LLC | 66,187,000 | $61,330,000 | 0.28% |
| RWC Asset Management LLP | 6,000,000 | $5,566,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,219,000 | $5,766,000 | 0.16% |